Crossmark

Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling

Published Online: 2025-11-14

Authors

Liang, Zhipin

Ma, Ruixia

Yi, Bin

Riker, Adam I.

Xi, Yaguang https://orcid.org/0000-0003-3681-9352
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA271533, R01CA260698, R01CA275089)

U.S. Department of Veterans Affairs (I01BX005094)
License Information

Text and Data Mining valid from 2025-11-14

Version of Record valid from 2025-11-14
More Information

Article History

Received: 25 June 2025

Revised: 10 October 2025

Accepted: 31 October 2025

First Online: 14 November 2025

Competing interests

: The authors declare no competing interests.

Document is current